Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 60588-81-0 | MDL No. : | MFCD11110226 |
Formula : | C6H6ClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VCJIRTWLMWNXEA-UHFFFAOYSA-N |
M.W : | 143.57 | Pubchem ID : | 10486967 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 35.37 |
TPSA : | 33.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.73 cm/s |
Log Po/w (iLOGP) : | 1.68 |
Log Po/w (XLOGP3) : | 0.63 |
Log Po/w (WLOGP) : | 1.08 |
Log Po/w (MLOGP) : | 0.49 |
Log Po/w (SILICOS-IT) : | 1.85 |
Consensus Log Po/w : | 1.15 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.55 |
Solubility : | 4.01 mg/ml ; 0.0279 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.9 |
Solubility : | 18.1 mg/ml ; 0.126 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.45 |
Solubility : | 0.514 mg/ml ; 0.00358 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.34 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
47% | Stage #1: With isopropyl chloroformate; triethylamine In tetrahydrofuran at 0 - 20℃; for 1 h; Stage #2: at 20℃; for 2 h; |
To a solution of 3-chloropyridine-2-carboxylic acid (2.1 g, 13.33 mmol, 1.00 equiv) in THF (40 mL) was added Et3N (2.7 g, 26.68 mmol, 2.00 equiv), followed by the addition of chloro(propan-2-yloxy)methanone (2.45 g, 19.99 mmol, 1.50 equiv) dropwise with stirring at 0° C. The solution was strried for 1 h at room temperture. The solid was removed by filtration. To the filtrate was added NaBH4 (1.53 g, 40.44 mmol, 3.00 equiv). The resulting solution was stirred for 2 h at rt, then diluted with 50 mL of H2O and extracted with 2*100 mL of EtOAc. The combined organic layers were washed with 50 mL of saturated Nacl, dried over Na2SO4, concentrated under vacuum, and purified with silica gel chromatography using with EtOAc/petroleum ether (1:6) to afford 0.9 g (47percent) of the title compound as a colorless oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | With methanesulfonyl chloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; for 3 h; | Synthesis of 3-chloro-2-(chloromethvDpyridine (32 31 To a solution of compound 31 (300 mg, 2.1 mmol) in DCM (4 mL) was added DIE A (539 mg, 4.2 mmol) at 0 °C, then MsCl (263 mg, 2.3 mmol) was added dropwise at 0 °C. The mixture was stirred at room temperature for 3h. Water was added, and the mixture was extracted with DCM, washed with sat. NaHCO and brine, dried over a?.S04, filtered, concentrated under reduced pressure to give compound 32 (240 mg, 69 percent) as a yellow oil. |
[ 275383-87-4 ]
(3,5-Dichloropyridin-2-yl)methanol
Similarity: 0.89
[ 1206968-88-8 ]
(5-Bromo-3-chloropyridin-2-yl)methanol
Similarity: 0.82
[ 124425-87-2 ]
3-Chloro-2-(chloromethyl)pyridine hydrochloride
Similarity: 0.81
[ 275383-87-4 ]
(3,5-Dichloropyridin-2-yl)methanol
Similarity: 0.89
[ 1206968-88-8 ]
(5-Bromo-3-chloropyridin-2-yl)methanol
Similarity: 0.82
[ 63071-10-3 ]
(4-Chloropyridin-2-yl)methanol
Similarity: 0.78
[ 209526-98-7 ]
(5-Chloropyridin-2-yl)methanol
Similarity: 0.73
[ 1263280-37-0 ]
3-Chloro-6-hydroxypicolinic acid
Similarity: 0.73
[ 275383-87-4 ]
(3,5-Dichloropyridin-2-yl)methanol
Similarity: 0.89
[ 1206968-88-8 ]
(5-Bromo-3-chloropyridin-2-yl)methanol
Similarity: 0.82
[ 124425-87-2 ]
3-Chloro-2-(chloromethyl)pyridine hydrochloride
Similarity: 0.81